The assessment of the mutational features has been the main objective of seminal studies shedding light on the frequency of FGFR3 alterations and other molecular features in urothelial carcinomas, focusing on localized diseases (2, 4, 5). Here, FGFR3 is linked to urothelial carcinoma.